I never said anyone was dumb. The ticker has moved
I never said anyone was dumb. The ticker has moved downward. The buy in price of my remaining shares is about 21.00 and it's value at market price is about 210.00.
I didn't even come here to debate the company or the stock. I didn't say anything positive or negative. I don't know why you had to start something when there was nothing. All I've done is offer to ask my nephew to talk about RMHB on his broadcast. Someone ask about my interest in being here because they were under the impression I sold everything. Then here you come starting drama. If you want to hold, then hold. I don't care what you do. I'm done debating about the company and the stock.
Rocky Mountain High Brands, Inc. (RMHB) Stock Research Links
Who needs wings when you can be ROCKY MOUNTAIN HIGH!
Have a Totally Hemp CraZy day
Long and Strong - RMHB
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Adobe's Options Activity Highlights In the world of finance, significant trades often signal important market sentiments. Recently, major investors have moved toward a bearish outlook on Adobe. Analyzing the options history for Adobe (NASDAQ: ADBE), we've identified a total of 67 significant trades. Our insights reveal that approximately 41% of these trades have been...
Continue Reading
Indonesia's Maritime Security Efforts Intensify Recently, Indonesia's maritime security has been under increased scrutiny as incidents involving a Chinese coast guard vessel continue to escalate. This week, a Chinese vessel was driven from Indonesian waters not once, but twice, after interfering with a critical energy survey conducted by Pertamina, the state energy...
Continue Reading
Welcome to the Future of Game Development Upheaval Games, founded by veterans from the gaming industry, embraces a new frontier in game design with the introduction of The Dreamer Portal. This innovative web-based interface allows creators to effortlessly build immersive game content with just a simple prompt. Imagine the power of crafting unique creatures, items, and...
Continue Reading
Alvotech and Advanz Pharma Collaborate for Biosimilar Approval REYKJAVIK and LONDON – Alvotech (NASDAQ: ALVO), a renowned biotechnology firm, along with Advanz Pharma, a leading global pharmaceutical company, has shared important news regarding the marketing approval of Gobivaz®, a proposed biosimilar to Simponi® (golimumab). This biologic treatment is designed for...
Continue Reading
Remote Patient Monitoring Set for Dynamic Growth The increasing prevalence of chronic conditions worldwide is expected to significantly accelerate the growth of the remote patient monitoring (RPM) market. As conditions like hypertension, diabetes, and cardiovascular diseases become more common, coupled with an aging population, healthcare systems face immense pressure to...
Continue Reading
